APTO - Aptose Biosciences Inc.
1.71
-1.440 -84.211%
Share volume: 670,384
Last Updated: 04-01-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$3.15
-1.44
-0.46%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-09-2024 | 03-28-2025 | 05-08-2025 | |
| Cash flow financing | 11.847 M | 4.754 M | 10.008 M | 6.805 M | 829.000 K | |
| Other financing cash flows | 3.702 M | -177.000 K | 0.000 | -3.523 M | 0.000 | |
| Cash flow | -1.907 M | 985.000 K | 0.000 | 0.000 | -1.966 M | |
| Net income | -9.640 M | -7.252 M | -6.953 M | -1.585 M | -5.543 M | |
| Depreciation | 16.000 K | 8.000 K | 4.000 K | 4.000 K | 3.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -1.991 M | 2.009 M | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -1.000 K | 0.000 | 0.000 | 23.000 K | 0.000 | |
| Cash Change | -1.906 M | 984.000 K | -368.000 K | -1.255 M | -1.964 M |